Click for best price
Alcoholic Hepatitis Therapeutic Market Size, Share 2023
| Market size in 2022 |
US$ 2743.7 million
|
Forecast Market size by 2029 |
US$ 3866.9 million
|
| Growth Rate |
CAGR of 5.0% |
Number of Pages |
66 Pages |
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It?s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can?t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
This report aims to provide a comprehensive presentation of the global market for Alcoholic Hepatitis Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alcoholic Hepatitis Therapeutic. This report contains market size and forecasts of Alcoholic Hepatitis Therapeutic in global, including the following market information:
Global Alcoholic Hepatitis Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Alcoholic Hepatitis Therapeutic market was valued at US$ 2743.7 million in 2022 and is projected to reach US$ 3866.9 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
We surveyed the Alcoholic Hepatitis Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alcoholic Hepatitis Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Alcoholic Hepatitis Therapeutic Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Global Alcoholic Hepatitis Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Alcoholic Hepatitis Therapeutic Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Research and Development
Global Alcoholic Hepatitis Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Alcoholic Hepatitis Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alcoholic Hepatitis Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Alcoholic Hepatitis Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alcoholic Hepatitis Therapeutic, market overview.
Chapter 2: Global Alcoholic Hepatitis Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Alcoholic Hepatitis Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alcoholic Hepatitis Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Alcoholic Hepatitis Therapeutic Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2743.7 million
|
| Forecast Market size by 2029 |
US$ 3866.9 million
|
| Growth Rate |
CAGR of 5.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Alcoholic Hepatitis Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alcoholic Hepatitis Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alcoholic Hepatitis Therapeutic Overall Market Size
2.1 Global Alcoholic Hepatitis Therapeutic Market Size: 2022 VS 2029
2.2 Global Alcoholic Hepatitis Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alcoholic Hepatitis Therapeutic Players in Global Market
3.2 Top Global Alcoholic Hepatitis Therapeutic Companies Ranked by Revenue
3.3 Global Alcoholic Hepatitis Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Alcoholic Hepatitis Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Alcoholic Hepatitis Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alcoholic Hepatitis Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Alcoholic Hepatitis Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Alcoholic Hepatitis Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alcoholic Hepatitis Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Caspase Protease Inhibitor
4.1.4 Corticosteroids
4.1.5 Hemorheologic Agents
4.1.6 Anabolic Steroids
4.1.7 Hepatotropic Hormones
4.1.8 Sulfhydryl Agents
4.1.9 Others
4.2 By Type - Global Alcoholic Hepatitis Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Alcoholic Hepatitis Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Alcoholic Hepatitis Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alcoholic Hepatitis Therapeutic Market Size, 2022 & 2029
5.1.2 Hospitals and Clinics
5.1.3 Research and Development
5.2 By Application - Global Alcoholic Hepatitis Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Alcoholic Hepatitis Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Alcoholic Hepatitis Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Alcoholic Hepatitis Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global Alcoholic Hepatitis Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Alcoholic Hepatitis Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Alcoholic Hepatitis Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Alcoholic Hepatitis Therapeutic Revenue, 2018-2029
6.3.2 US Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.3.3 Canada Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.3.4 Mexico Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Alcoholic Hepatitis Therapeutic Revenue, 2018-2029
6.4.2 Germany Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4.3 France Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4.4 U.K. Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4.5 Italy Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4.6 Russia Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.4.8 Benelux Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Alcoholic Hepatitis Therapeutic Revenue, 2018-2029
6.5.2 China Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.5.3 Japan Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.5.4 South Korea Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.5.6 India Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Alcoholic Hepatitis Therapeutic Revenue, 2018-2029
6.6.2 Brazil Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.6.3 Argentina Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alcoholic Hepatitis Therapeutic Revenue, 2018-2029
6.7.2 Turkey Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.7.3 Israel Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
6.7.5 UAE Alcoholic Hepatitis Therapeutic Market Size, 2018-2029
7 Alcoholic Hepatitis Therapeutic Companies Profiles
7.1 Alkermes
7.1.1 Alkermes Company Summary
7.1.2 Alkermes Business Overview
7.1.3 Alkermes Alcoholic Hepatitis Therapeutic Major Product Offerings
7.1.4 Alkermes Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Alkermes Key News & Latest Developments
7.2 Conatus pharmaceuticals
7.2.1 Conatus pharmaceuticals Company Summary
7.2.2 Conatus pharmaceuticals Business Overview
7.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Major Product Offerings
7.2.4 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Conatus pharmaceuticals Key News & Latest Developments
7.3 Dainippon sumitomo pharma
7.3.1 Dainippon sumitomo pharma Company Summary
7.3.2 Dainippon sumitomo pharma Business Overview
7.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Major Product Offerings
7.3.4 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Dainippon sumitomo pharma Key News & Latest Developments
7.4 Generon corporation
7.4.1 Generon corporation Company Summary
7.4.2 Generon corporation Business Overview
7.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Major Product Offerings
7.4.4 Generon corporation Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Generon corporation Key News & Latest Developments
7.5 Immuron limited
7.5.1 Immuron limited Company Summary
7.5.2 Immuron limited Business Overview
7.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Major Product Offerings
7.5.4 Immuron limited Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Immuron limited Key News & Latest Developments
7.6 Lupin Laboratories
7.6.1 Lupin Laboratories Company Summary
7.6.2 Lupin Laboratories Business Overview
7.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Major Product Offerings
7.6.4 Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Lupin Laboratories Key News & Latest Developments
7.7 Intercept Pharmaceuticals
7.7.1 Intercept Pharmaceuticals Company Summary
7.7.2 Intercept Pharmaceuticals Business Overview
7.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Major Product Offerings
7.7.4 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.7.5 Intercept Pharmaceuticals Key News & Latest Developments
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Company Summary
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Major Product Offerings
7.8.4 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceuticals Key News & Latest Developments
7.9 Sanofi-Aventis
7.9.1 Sanofi-Aventis Company Summary
7.9.2 Sanofi-Aventis Business Overview
7.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Major Product Offerings
7.9.4 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue in Global Market (2018-2023)
7.9.5 Sanofi-Aventis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Alcoholic Hepatitis Therapeutic Market Opportunities & Trends in Global Market
Table 2. Alcoholic Hepatitis Therapeutic Market Drivers in Global Market
Table 3. Alcoholic Hepatitis Therapeutic Market Restraints in Global Market
Table 4. Key Players of Alcoholic Hepatitis Therapeutic in Global Market
Table 5. Top Alcoholic Hepatitis Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Alcoholic Hepatitis Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Alcoholic Hepatitis Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Alcoholic Hepatitis Therapeutic Product Type
Table 9. List of Global Tier 1 Alcoholic Hepatitis Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alcoholic Hepatitis Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Alcoholic Hepatitis Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Alcoholic Hepatitis Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Alcoholic Hepatitis Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Alcoholic Hepatitis Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Alcoholic Hepatitis Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Alcoholic Hepatitis Therapeutic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2024-2029
Table 30. Alkermes Company Summary
Table 31. Alkermes Alcoholic Hepatitis Therapeutic Product Offerings
Table 32. Alkermes Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 33. Alkermes Key News & Latest Developments
Table 34. Conatus pharmaceuticals Company Summary
Table 35. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offerings
Table 36. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 37. Conatus pharmaceuticals Key News & Latest Developments
Table 38. Dainippon sumitomo pharma Company Summary
Table 39. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product Offerings
Table 40. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 41. Dainippon sumitomo pharma Key News & Latest Developments
Table 42. Generon corporation Company Summary
Table 43. Generon corporation Alcoholic Hepatitis Therapeutic Product Offerings
Table 44. Generon corporation Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 45. Generon corporation Key News & Latest Developments
Table 46. Immuron limited Company Summary
Table 47. Immuron limited Alcoholic Hepatitis Therapeutic Product Offerings
Table 48. Immuron limited Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 49. Immuron limited Key News & Latest Developments
Table 50. Lupin Laboratories Company Summary
Table 51. Lupin Laboratories Alcoholic Hepatitis Therapeutic Product Offerings
Table 52. Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 53. Lupin Laboratories Key News & Latest Developments
Table 54. Intercept Pharmaceuticals Company Summary
Table 55. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offerings
Table 56. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 57. Intercept Pharmaceuticals Key News & Latest Developments
Table 58. Teva Pharmaceuticals Company Summary
Table 59. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Offerings
Table 60. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceuticals Key News & Latest Developments
Table 62. Sanofi-Aventis Company Summary
Table 63. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product Offerings
Table 64. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi-Aventis Key News & Latest Developments
List of Figures
Figure 1. Alcoholic Hepatitis Therapeutic Segment by Type in 2022
Figure 2. Alcoholic Hepatitis Therapeutic Segment by Application in 2022
Figure 3. Global Alcoholic Hepatitis Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Alcoholic Hepatitis Therapeutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Alcoholic Hepatitis Therapeutic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alcoholic Hepatitis Therapeutic Revenue in 2022
Figure 8. By Type - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 16. US Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 20. Germany Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 21. France Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 28. China Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 32. India Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 34. Brazil Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Alcoholic Hepatitis Therapeutic Revenue Market Share, 2018-2029
Figure 37. Turkey Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Alcoholic Hepatitis Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 41. Alkermes Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Generon corporation Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Immuron limited Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
